Tokyo Tape
Sign in
← Fukuda Denshi

Quarterly report · Q3

6960.TEDINET S100Q3IX
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥93.5bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥132.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥93.1bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥16.1bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥15.9bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥16.8bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥23.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥16.3bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥16.9bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥16.8bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥16.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥11.6bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥11.6bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥195.2bnat 2022-12-31Cons.Assets
Total assets¥195.5bnat 2022-03-31Cons.Assets
Total assets¥183.2bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥38.6bnat 2022-12-31Cons.Liabilities
Total liabilities¥45.6bnat 2022-03-31Cons.Liabilities
Net assets / equity¥156.6bnat 2022-12-31Cons.Net assets
Net assets / equity¥149.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥145.2bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥63.3bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥64.1bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥383.712022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥115.282022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥536.192021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥382.892021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥135.082021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio80.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio79.3%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥25.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥25.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥40.5bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥40.5bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.9bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥7.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥7.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥20.0bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.0bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥3.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥16.1bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue2021-04-01 → 2021-12-31¥24.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue external2021-04-01 → 2021-12-31¥24.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentsegment profit2021-04-01 → 2021-12-31¥3.4bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2021-04-01 → 2021-12-31¥40.4bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2021-04-01 → 2021-12-31¥40.4bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2021-04-01 → 2021-12-31¥8.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2021-04-01 → 2021-12-31¥9.3bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2021-04-01 → 2021-12-31¥9.3bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2021-04-01 → 2021-12-31¥1.5bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2021-04-01 → 2021-12-31¥18.8bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2021-04-01 → 2021-12-31¥18.8bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2021-04-01 → 2021-12-31¥2.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥93.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥93.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥15.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 372
ItemContextValueUnit
Provision for bonusesPrior1YearInstant3439000000JPY
Provision for bonusesCurrentQuarterInstant1520000000JPY
Provision for product warrantiesPrior1YearInstant117000000JPY
Provision for product warrantiesCurrentQuarterInstant136000000JPY
Other provision clPrior1YearInstant579000000JPY
Other provision clCurrentQuarterInstant386000000JPY
Other clPrior1YearInstant7339000000JPY
Other clCurrentQuarterInstant7233000000JPY
Current liabilitiesPrior1YearInstant38829000000JPY
Current liabilitiesCurrentQuarterInstant31783000000JPY
Net defined benefit liabilityPrior1YearInstant3137000000JPY
Net defined benefit liabilityCurrentQuarterInstant3189000000JPY
Other provision nclPrior1YearInstant752000000JPY
Other provision nclCurrentQuarterInstant717000000JPY
Other nclPrior1YearInstant2918000000JPY
Other nclCurrentQuarterInstant2957000000JPY
Noncurrent liabilitiesPrior1YearInstant6809000000JPY
Noncurrent liabilitiesCurrentQuarterInstant6865000000JPY
LiabilitiesPrior1YearInstant45638000000JPY
LiabilitiesCurrentQuarterInstant38648000000JPY
Capital stockPrior1YearInstant4621000000JPY
Capital stockCurrentQuarterInstant4621000000JPY
Capital surplusPrior1YearInstant21841000000JPY
Capital surplusCurrentQuarterInstant21839000000JPY
Retained earningsPrior1YearInstant142135000000JPY
Retained earningsCurrentQuarterInstant148483000000JPY
Treasury stockPrior1YearInstant-20362000000JPY
Treasury stockCurrentQuarterInstant-20353000000JPY
Shareholders equityPrior1YearInstant148236000000JPY
Shareholders equityCurrentQuarterInstant154591000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant1836000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant1939000000JPY
Foreign currency translation adjustmentPrior1YearInstant-11000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant198000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-204000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-172000000JPY
Valuation and translation adjustmentsPrior1YearInstant1621000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant1965000000JPY
Net assetsPrior1YearInstant149857000000JPY
Net assetsCurrentQuarterInstant156556000000JPY
Liabilities and net assetsPrior1YearInstant195495000000JPY
Liabilities and net assetsCurrentQuarterInstant195205000000JPY
Net salesPrior1YTDDuration93068000000JPY
Net salesCurrentYTDDuration93481000000JPY
Cost of salesPrior1YTDDuration45752000000JPY
Cost of salesCurrentYTDDuration44436000000JPY
Gross profitPrior1YTDDuration47315000000JPY
Gross profitCurrentYTDDuration49044000000JPY
Selling general and administrative expensesPrior1YTDDuration31452000000JPY
Selling general and administrative expensesCurrentYTDDuration32966000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass